Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Efavirenz/lamivudine/tenofovir

Development of resistance to tenofovir: 2 case reports

    • 3 Accesses

    This is a preview of subscription content, log in to check access.

    Reference

    1. Schwem B, et al. Residual lamivudine-resistant hepatitis B virus detected on next-generation sequencing of treatment-experienced HIV patients failing antiretrovirals. Open Forum Infectious Diseases 6 (Suppl. 2): S189 abstr. 361, Oct 2019. Available from: URL: http://doi.org/10.1093/ofid/ofz360.434 [abstract]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Efavirenz/lamivudine/tenofovir. Reactions Weekly 1791, 106 (2020). https://doi.org/10.1007/s40278-020-74951-3

    Download citation